Skin cancers in Madagascar: where do we stand?

被引:0
|
作者
Malalaniaina, Andrianarison [1 ]
Lovasoa, Tika [2 ]
Mamisoa, Ranaivo Irina [3 ]
Malala, Razakanaivo [2 ]
Soavina, Ramarozatovo Lala [4 ]
Florine, Rafaramino [2 ]
Fahafahantsoa, Rapelanoro Rabenja [1 ]
机构
[1] Ctr Hosp Univ Joseph Raseta Befelatanana, Serv Dermatol, Antananarivo, Madagascar
[2] Ctr Hosp Univ Joseph Raseta Befelatanana, Serv Oncol, Antananarivo, Madagascar
[3] Ctr Hosp Univ Morafeno, Serv Dermatol, Tamatave, Madagascar
[4] Ctr Hosp Unversitaire Joseph Raseta Befelata, Serv Med Interne & Dermatol, Antananarivo, Madagascar
来源
关键词
Skin cancers; carcinomas; epidemiology; melanoma; Madagascar; MELANOMA; DERMATOLOGY;
D O I
10.11604/pamj.2019.34.167.19269
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: skin cancers are malignant keratinizing tumors of epidermal, melaninic or adnexal origin. These cancers are still little known. However they affect people living in Madagascar where the amount of sunshine remains very high with an impact that varies depending on the skin type. The purpose of our study was to determine the epidemio-clinical profile of skin cancers in Antananarivo. Methods: we conducted a retrospective descriptive study of skin cancers in the Department of Oncology of the Joseph Ravoahangy Andrianavalona Hospital, Antananarivo over a period of seven years. It included patients with tumoral skin lesions confirmed by histological examination. Results: we collected data from 47 cases of skin cancers (male predominance; sex ratio 1.13). The average age of patients was 49.3 years. Farmers were the most affected. The lesions mainly occurred in the head, neck (44%) and lower limbs (42%). Localized skin cancers were detected in 61.7% of cases. Squamous cell carcinoma was the most common skin cancer in Madagascar (37%), followed by the melanoma (21%) and the basal cell carcinoma (11%). Treatment was mainly based on surgery (74.19%). Conclusion: squamous cell carcinoma is the most common cancer in Madagascar, followed by melanoma and basal cell carcinoma. Skin cancers affect mainly the young population and require appropriate management.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Where do we stand with immunotherapy for nonmelanoma skin cancers in the curative setting?
    Alberti, Andrea
    Gurizzan, Cristina
    Baggi, Alice
    Bossi, Paolo
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2024, 32 (02): : 89 - 95
  • [2] Opioids and the skin - where do we stand?
    Bigliardi, Paul L.
    Tobin, Desmond J.
    Gaveriaux-Ruff, Claire
    Bigliardi-Qi, Mei
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (05) : 424 - 430
  • [3] Vascularization in skin wound healing: where do we stand and where do we go
    Moreira, Helena R.
    Marques, Alexandra P.
    CURRENT OPINION IN BIOTECHNOLOGY, 2022, 73 : 253 - 262
  • [4] Nanocarriers for Skin Applications: Where Do We Stand?
    Tiwari, Neha
    Osorio-Blanco, Ernesto Rafael
    Sonzogni, Ana
    Esporrin-Ubieto, David
    Wang, Huiyi
    Calderon, Marcelo
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 61 (03)
  • [5] Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
    Hu, Li-Feng
    Lan, Huan-Rong
    Huang, Dong
    Li, Xue-Min
    Jin, Ke-Tao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Chemoprevention of breast and prostate cancers: where do we stand?
    Senn, H. J.
    Morant, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 234 - 237
  • [7] Skin ultrasound in systemic sclerosis: Where do we stand and where shall we go?
    Santiago, Tania
    Da Silva, Jose Antonio P.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (02) : 193 - 194
  • [8] Where do we stand?
    Thompson, ID
    FORESTRY CHRONICLE, 2003, 79 (03): : 381 - 382
  • [10] Where do we stand?
    Catt, Graham
    AUSTRALIAN VETERINARY JOURNAL, 2008, 86 (07) : N8 - N8